SOOSAN INT Co., Ltd. (KOSDAQ:050960)
South Korea · Delayed Price · Currency is KRW 10,690
+40 (0.38%)
Last updated: Aug 7, 2025
Ligand Pharmaceuticals Revenue
In the year 2023, SOOSAN INT had annual revenue of 23.89B KRW with 9.49% growth.
Revenue
23.89B
Revenue Growth
+9.49%
P/S Ratio
3.06
Revenue / Employee
271.44M
Employees
88
Market Cap
72.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 23.89B | 2.07B | 9.49% |
| Dec 31, 2022 | 21.82B | -3.20B | -12.80% |
| Dec 31, 2021 | 25.02B | 2.06B | 8.98% |
| Dec 31, 2020 | 22.96B | 6.96B | 43.48% |
| Dec 31, 2019 | 16.00B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| HD Hyundai Heavy Industries | 15.32T |